Intermittent for Urinary Tract Infections

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
The Ottawa Hospital, Ottawa, Canada
Urinary Tract Infections+3 More
Indwelling Catheter - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The primary aim of the proposed pilot feasibility is to determine whether it is feasible to recruit patients with a hip fracture into a prospective study and randomize them to either indwelling or intermittent catheterization. The study hypothesis is that the investigators would be able to show that this study can be incorporated into clinical practice, with satisfactory rate of patient recruitment and retention. Thus, the investigators would be able to compete this pilot study trial and proceed towards a multi-center trial.

Eligible Conditions

  • Urinary Tract Infections
  • Urogenital
  • Complications; Catheter
  • Hip Fractures

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Urinary Tract Infections

Study Objectives

4 Primary · 3 Secondary · Reporting Duration: One year

30 days
Safety-Related Outcomes - Rates of POUR
Safety-Related Outcomes - Rates of UTI
One year
Study Feasibility - Enrollment
Study Feasibility - Follow-up
Study Feasibility - Retention
Study Feasibility - Screening
pre-operatively, and post-operative day six or at discharge
patient experience questionnaire

Trial Safety

Safety Progress

1 of 3

Other trials for Urinary Tract Infections

Trial Design

2 Treatment Groups

Intermittent
1 of 2
Indwelling
1 of 2
Experimental Treatment

120 Total Participants · 2 Treatment Groups

Primary Treatment: Intermittent · No Placebo Group · N/A

Intermittent
Device
Experimental Group · 1 Intervention: Intermittent Catheterization · Intervention Types: Device
Indwelling
Device
Experimental Group · 1 Intervention: Indwelling Catheter · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Indwelling Catheter
2016
N/A
~1480

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: one year
Closest Location: The Ottawa Hospital · Ottawa, Canada
Photo of Ottawa  1Photo of Ottawa  2Photo of Ottawa  3
2001First Recorded Clinical Trial
1 TrialsResearching Urinary Tract Infections
223 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
Operative treatment is planned for all patients.
You are willing and able to sign consent.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References